Ong HX - Search Results

1

Primary Air-Liquid Interface Culture of Nasal Epithelium for Nasal Drug Delivery.

Ong HX, Jackson CL, Cole JL, Lackie PM, Traini D, Young PM, Lucas J, Conway J. Ong HX, et al. Mol Pharm. 2016 Jul 5;13(7):2242-52. doi: 10.1021/acs.molpharmaceut.5b00852. Epub 2016 Jun 9. Mol Pharm. 2016. PMID: 27223825

2

Epithelial profiling of antibiotic controlled release respiratory formulations.

Ong HX, Traini D, Bebawy M, Young PM. Ong HX, et al. Pharm Res. 2011 Sep;28(9):2327-38. doi: 10.1007/s11095-011-0462-1. Epub 2011 May 26. Pharm Res. 2011. PMID: 21614637

3

Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.

Ong HX, Traini D, Cipolla D, Gonda I, Bebawy M, Agus H, Young PM. Ong HX, et al. Pharm Res. 2012 Dec;29(12):3335-46. doi: 10.1007/s11095-012-0827-0. Epub 2012 Jul 26. Pharm Res. 2012. PMID: 22833052

4

Multiple dosing of simvastatin inhibits airway mucus production of epithelial cells: implications in the treatment of chronic obstructive airway pathologies.

Marin L, Traini D, Bebawy M, Colombo P, Buttini F, Haghi M, Ong HX, Young P. Marin L, et al. Among authors: ong hx. Eur J Pharm Biopharm. 2013 Aug;84(3):566-72. doi: 10.1016/j.ejpb.2013.01.021. Epub 2013 Mar 7. Eur J Pharm Biopharm. 2013. PMID: 23474382

5

Ciprofloxacin is actively transported across bronchial lung epithelial cells using a Calu-3 air interface cell model.

Ong HX, Traini D, Bebawy M, Young PM. Ong HX, et al. Antimicrob Agents Chemother. 2013 Jun;57(6):2535-40. doi: 10.1128/AAC.00306-13. Epub 2013 Mar 18. Antimicrob Agents Chemother. 2013. PMID: 23507281 Free PMC article.

6

Pharmaceutical applications of the Calu-3 lung epithelia cell line.

Ong HX, Traini D, Young PM. Ong HX, et al. Expert Opin Drug Deliv. 2013 Sep;10(9):1287-302. doi: 10.1517/17425247.2013.805743. Epub 2013 Jun 4. Expert Opin Drug Deliv. 2013. PMID: 23730924 Review.

7

The effects of mannitol on the transport of ciprofloxacin across respiratory epithelia.

Ong HX, Traini D, Salama R, Anderson SD, Daviskas E, Young PM. Ong HX, et al. Mol Pharm. 2013 Aug 5;10(8):2915-24. doi: 10.1021/mp400030n. Epub 2013 Jul 11. Mol Pharm. 2013. PMID: 23803159

8

In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation.

Ong HX, Benaouda F, Traini D, Cipolla D, Gonda I, Bebawy M, Forbes B, Young PM. Ong HX, et al. Eur J Pharm Biopharm. 2014 Jan;86(1):83-9. doi: 10.1016/j.ejpb.2013.06.024. Epub 2013 Jul 10. Eur J Pharm Biopharm. 2014. PMID: 23851077

9

Combined inhaled salbutamol and mannitol therapy for mucus hyper-secretion in pulmonary diseases.

Ong HX, Traini D, Ballerin G, Morgan L, Buddle L, Scalia S, Young PM. Ong HX, et al. AAPS J. 2014 Mar;16(2):269-80. doi: 10.1208/s12248-014-9560-4. Epub 2014 Jan 16. AAPS J. 2014. PMID: 24431080 Free PMC article.

10

A novel inhalable form of rifapentine.

Chan JG, Duke CC, Ong HX, Chan JC, Tyne AS, Chan HK, Britton WJ, Young PM, Traini D. Chan JG, et al. Among authors: ong hx. J Pharm Sci. 2014 May;103(5):1411-21. doi: 10.1002/jps.23911. Epub 2014 Mar 1. J Pharm Sci. 2014. PMID: 24585270

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters